You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idiopathic Hypersomnia

Showing 1 - 25 of 2,402
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Hypersomnia Trial in Paris (EEG (64 electrodes), Cognitive task (SART), Pupillometry and eye tracking)

Not yet recruiting
  • Idiopathic Hypersomnia
  • EEG (64 electrodes)
  • +3 more
  • Paris, France
    Pitié Salpêtrière
Nov 29, 2023

Idiopathic Hypersomnia, Narcolepsy Trial (JZP258 (XYWAV))

Not yet recruiting
  • Idiopathic Hypersomnia
  • Narcolepsy
  • JZP258 (XYWAV)
  • (no location specified)
May 16, 2023

Psychiatric Co-morbidities and Socio-demographic Characteristics

Recruiting
  • Idiopathic Hypersomnia
  • +2 more
  • respond to questionnaires by telephone
  • Toulouse, France
    Chu Toulouse
Mar 9, 2023

Idiopathic Hypersomnia Trial in United States (drug, diagnostic test, device)

Not yet recruiting
  • Idiopathic Hypersomnia
  • Low Sodium Oxybate
  • +3 more
  • Phoenix, Arizona
  • +3 more
Apr 19, 2023

Narcolepsy, Social Cognition Trial in Amiens (Questionary)

Recruiting
  • Narcolepsy
  • Social Cognition
  • Questionary
  • Amiens, France
    CHU Amiens-Picardie
Mar 17, 2023

Idiopathic Hypersomnia, Narcolepsy Without Cataplexy Trial in Atlanta (Modafinil, Amphetamine-Dextroamphetamine)

Recruiting
  • Idiopathic Hypersomnia
  • Narcolepsy Without Cataplexy
  • Atlanta, Georgia
    Emory Sleep Center
Jul 13, 2022

Narcolepsy Without Cataplexy, Idiopathic Hypersomnia Trial in Atlanta (Clarithromycin, Placebo)

Recruiting
  • Narcolepsy Without Cataplexy
  • Idiopathic Hypersomnia
  • Atlanta, Georgia
    Emory Sleep Center
Jun 15, 2022

Narcolepsy, Idiopathic Hypersomnia, Cataplexy Trial (Quantitative mass spectrometry assay)

Not yet recruiting
  • Narcolepsy
  • +2 more
  • Quantitative mass spectrometry assay
  • (no location specified)
Nov 7, 2022

Cardiovascular and Cognitive Implications of Central Disorders

Enrolling by invitation
  • Narcolepsy
  • Idiopathic Hypersomnia
  • 24-hour Ambulatory Blood Pressure Monitoring
  • Oculo-Cognitive Addition Test (OCAT)
  • Scottsdale, Arizona
    Mayo Clinic Arizona
May 27, 2022

Sleep Disorder, Sleep Disorder Parasomnia, Narcolepsy Trial in Mainz (no interventions, only observation)

Recruiting
  • Sleep Disorder
  • +8 more
  • Implantation of vagus nerve stimulation according to clinical indication
  • Mainz, Rheinland-Pfalz, Germany
    Mainz Comprehensive Epilepsy and Sleep Medicine Center
Sep 11, 2022

Narcolepsy, Idiopathic Hypersomnia, Hypersomnolence Disorder Trial in Bern

Recruiting
  • Narcolepsy
  • +2 more
    • Bern, Switzerland
      Claudio L Bassetti
    May 17, 2022

    Anesthetic Management of Patients With Chronic Sleep Disorders

    Completed
    • Narcolepsy
    • +2 more
    • Questionnaire
    • Montpellier, France
      Uhmontpellier
    Sep 6, 2021

    Idiopathic Hypersomnia Trial in United States (Serdexmethylphenidate, Placebo)

    Recruiting
    • Idiopathic Hypersomnia
    • Birmingham, Alabama
    • +34 more
    Dec 29, 2022

    Idiopathic Hypersomnia Trial in Montpellier (Sodium Oxybate Oral Solution 500 MG/ML, Placebos)

    Recruiting
    • Idiopathic Hypersomnia
    • Sodium Oxybate Oral Solution 500 MG/ML
    • Placebos
    • Montpellier, France
      University Hospital of Montpellier
    Feb 11, 2021

    Idiopathic Hypersomnia, Excessive Daytime Sleepiness Trial in United States (pitolisant)

    Enrolling by invitation
    • Idiopathic Hypersomnia
    • Excessive Daytime Sleepiness
    • Peoria, Arizona
    • +57 more
    Nov 10, 2022

    Idiopathic Hypersomnia Trial in United States (Pitolisant Oral Tablet, Placebo oral tablet)

    Recruiting
    • Idiopathic Hypersomnia
    • Pitolisant Oral Tablet
    • Placebo oral tablet
    • Scottsdale, Arizona
    • +50 more
    Jun 14, 2022

    Importance of Sleep Deprivation in Differential Diagnosis of

    Completed
    • Hypersomnia
      • Garches, Ile De France, France
        Hôpital raymond Poincaré
      Jan 25, 2021

      Narcolepsy 1, Idiopathic Hypersomnia Trial in Zürich (Sleep restriction, Sleep deprivation)

      Completed
      • Narcolepsy 1
      • Idiopathic Hypersomnia
      • Sleep restriction
      • Sleep deprivation
      • Zürich, Switzerland
        University Hospital Zurich
      Feb 19, 2021

      Idiopathic Hypersomnia Trial in Japan, United States (TAK-925, TAK-925 Placebo)

      Completed
      • Idiopathic Hypersomnia
      • Alabaster, Alabama
      • +21 more
      Mar 4, 2021

      Idiopathic Hypersomnia Trial in Worldwide (JZP-258, Placebo Oral Solution)

      Completed
      Has Results
      • Idiopathic Hypersomnia
      • Birmingham, Alabama
      • +62 more
      Nov 18, 2021

      Idiopathic Hypersomnia Trial in United States (Pentetrazol (PTZ), Placebo oral capsule)

      Unknown status
      • Idiopathic Hypersomnia
      • Pentetrazol (PTZ)
      • Placebo oral capsule
      • Birmingham, Alabama
      • +31 more
      Apr 28, 2020

      Narcolepsy, Idiopathic Hypersomnia Trial in Chicago (Cognitive-Behavior Therapy for Hypersomnia (CBT-H))

      Completed
      • Narcolepsy
      • Idiopathic Hypersomnia
      • Cognitive-Behavior Therapy for Hypersomnia (CBT-H)
      • Chicago, Illinois
        Center for Circadian and Sleep Medicine, Northwestern University
      Nov 19, 2019

      Disentangling the Role of Depression in Hypersomnia

      Not yet recruiting
      • Hypersomnia
      • Sleep study
      • Philadelphia, Pennsylvania
        The University of Pennsylvania
      May 10, 2023

      Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

      Recruiting
      • Rare Disorders
      • +309 more
        • Sioux Falls, South Dakota
        • +1 more
        Jun 20, 2022

        Hypersomnia Trial in Columbus (Transcranial Direct Current Stimulation, Sham stimulation)

        Terminated
        Has Results
        • Hypersomnia
        • Transcranial Direct Current Stimulation
        • Sham stimulation
        • Columbus, Ohio
          The Ohio State University
        Oct 22, 2021